Tuesday, 27 October 2026LatestVideosAboutContact
Latest
Ganesh Acharya turns lyricist for the first time with ‘Kar Mehnat’, sung by Sonu NigamSterling Anderson doesn’t think humanoid robots should be building carsDelhi Police Says Permission For Congress Rally At Ramlila Maidan Has Not Been Withdrawn: ReportIndia seeks bigger share of diesel exports on refining capacity boomHigh Salary, Low Savings: Why Earning More Does Not Always Mean Financial FreedomLoan Against Property: How to Plan EMI, Tenure and Repayment Before BorrowingMaruti Suzuki Profit Misses Estimate as Costs Squeeze MarginsCopper vs Aluminium: What’s next for metal prices this year? | Trending commodity picks | EP 121ICICI Prudential Mutual Fund launches BSE Power ETF; NFO open until October 30Boos for ad-breaks, premature tributes to ‘winners’: 3-hour long Ballon D’Or ceremony draws flakIHM-Hyderabad hosts fifth season of national hospitality competitions5 wicketkeepers WPL teams could target at the auction
BusinessUpdated 1 hr ago

GSK to nearly double cancer drugs in trials next year, WSJ reports

BusinessLine27 October 2026 at 3:24 pm IST
Image: BusinessLine

In July, GSK said it expected to have more than 20 late-stage studies by the end of 2026, with three of the seven drugs identified for faster development ‌being cancer medicines

Continue reading on BusinessLine

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all

India seeks bigger share of diesel exports on refining capacity boom

BusinessLine8 min ago

High Salary, Low Savings: Why Earning More Does Not Always Mean Financial Freedom

ABP Live8 min ago

Maruti Suzuki Profit Misses Estimate as Costs Squeeze Margins

Mint9 min ago

Copper vs Aluminium: What’s next for metal prices this year? | Trending commodity picks | EP 121

BusinessLine11 min ago